Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237.
Dreyer ZE, Kadota RP, Stewart CF, Friedman HS, Mahoney DH, Kun LE, McCluggage CW, Burger PC, Kepner J, Heideman RL; Pediatric Oncology Group.
Dreyer ZE, et al. Among authors: kadota rp.
Neuro Oncol. 2003 Oct;5(4):261-7. doi: 10.1215/S115285170200056X.
Neuro Oncol. 2003.
PMID: 14565163
Free PMC article.
Clinical Trial.